Skip to content

UFP Technologies

US · UFPT #2677 by market cap Listed 1970
290.85 -8.08 -2.70%
Periodic snapshot; not a real-time feed. · 2026-11-20 20:02

✦ Quant Ownership Signal how this is computed

Distributing
  • The number of reporting institutions increased by 19 in the most recent period (2026/Q3).
  • Total institutional ownership fell 7.7 percentage points.

Ownership vs. money flow

Aligned

Institutions trimmed shares last reporting period, and the stock has seen net outflows in main-fund flow over the last 20 trading sessions - the two line up.

Institutional ownership changes are reported quarterly with a lag; fund-flow data is daily. Treat this as a directional cross-check, not a precise timing signal.

Institutional ownership

Held by institutions
117.04% -7.75pp
Institutions
358 +19
As of
2026/Q3 vs. prior period

Holder types

Mutual Fund105.93%
Hedge Fund4.75%
Individual/Insider3.42%
Public Company3.03%
Government Pension Fund1.73%
Family Office/Trust0.55%
Insurance Company0.44%
Private Company0.39%
Sovereign Wealth Fund0.13%

Top holders as of 2026-09-30

BlackRock 14.69% · 1.14M sh
Congress Asset Management Company, LLP 7.47% · 578.77K sh
Wasatch Advisors LP 7.14% · 552.81K sh
Neuberger Berman Investment Advisers LLC 6.93% · 537.04K sh
T. Rowe Price Group, Inc. 4.61% · 357.33K sh
Vanguard Capital Management, LLC 4.25% · 329.30K sh
Boston Trust Walden National Association 4.14% · 320.34K sh
State Street Global Advisors 4.06% · 314.69K sh
Thrivent Investment Management, Inc. 3.08% · 238.89K sh
American Century Investment Management 3.61% · 279.98K sh
UBS Asset Management 3.46% · 268.10K sh
MFS Investment Management 2.88% · 223.47K sh

Bar length is relative to the largest holder shown here, not to 100% of the company.

Insiders

50 filings tracked · 26 buys · 23 sells

NameRoleStake
R. Bailly Executive Chairperson 1.73%
Ronald Lataille CFO, Senior VP & Treasurer 0.59%
Mitchell Rock Chief Executive Officer 0.35%
Marc Kozin Independent Director 0.26%
Thomas Oberdorf Independent Director 0.16%
Christopher Litterio Former General Counsel, Secretary & Senior VP of Human Resources 0.11%
Jason Holt Senior Vice President 0.07%
Steven Cardin Former VP & COO of MedTech 0.05%
Cynthia Feldmann Independent Director 0.05%
Joseph Hassett Independent Director 0.02%

Insider transactions most recent Form 4 filings

DateNameRoleTypeSharesPrice
2026-08-24 Marc Kozin Independent Director Open Market Disposition -7,000 $303.97–305.07
2026-08-17 Symeria Hudson Independent Director Open Market Disposition -298 $319.11
2026-08-13 Symeria Hudson Independent Director Derivative Exercise and Sale -1,196 $167.98–324.58
2026-08-13 Symeria Hudson Independent Director Open Market Disposition -730 $324.58
2026-08-13 Symeria Hudson Independent Director Intent to Sell (Form 144) -2,224 --
2026-08-12 Cynthia Feldmann Independent Director Open Market Disposition -1,000 $324.26
2026-08-09 R. Bailly Executive Chairperson Open Market Disposition -13,011 $315.53–317.27
2026-08-06 R. Bailly Executive Chairperson Open Market Disposition -15,695 $315.06–320.05
2026-08-05 Christopher Litterio Former General Counsel, Secretary & Senior VP of Human Resources Intent to Sell (Form 144) -1,000 $322.00
2026-08-05 Jason Holt Senior Vice President Open Market Disposition -1,100 $317.00
2026-06-11 Cynthia Feldmann Independent Director Derivative Exercise and Sale -1,200 $43.95–240.40
2026-06-04 R. Bailly Executive Chairperson Sale to Issuer -750 $223.87
2026-06-04 R. Bailly Executive Chairperson Other Acquisition +1,787 --
2026-06-03 Ronald Lataille CFO, Senior VP & Treasurer Other Acquisition +4,454 --
2026-06-03 Thomas Oberdorf Independent Director Other Acquisition +802 --
2026-06-03 Daniel Croteau Lead Independent Director Other Acquisition +802 --
2026-06-03 Marc Kozin Independent Director Other Acquisition +802 --
2026-06-03 Mitchell Rock Chief Executive Officer Other Acquisition +2,895 --
2026-06-03 Cynthia Feldmann Independent Director Other Acquisition +802 --
2026-06-03 Joseph Hassett Independent Director Other Acquisition +802 --

Form 4 filings, most recent per company. "Other Derivative Acquisition" rows are mostly RSU/option vesting, not open-market buying - the Type column says which.

Quote time 2026-11-20 20:02:18 · For reference only, not investment advice and not tailored to your situation.

UFP Technologies discussion 0 comments

Add a comment